Log in

NASDAQ:PTEPolarityte Stock Price, Forecast & News

-0.09 (-5.84 %)
(As of 08/12/2020 04:00 PM ET)
Today's Range
Now: $1.45
50-Day Range
MA: $1.45
52-Week Range
Now: $1.45
Volume347,000 shs
Average Volume913,741 shs
Market Capitalization$56.17 million
P/E RatioN/A
Dividend YieldN/A
PolarityTE, Inc., a biotechnology and regenerative biomaterials company, focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine and Contract Services. It offers SkinTE, a tissue product for treatment of defects of the skin, as well as contract research services. The company also develops OsteoTE, an autologous homologous bone regeneration product; and CartTE, an autologous cartilage regeneration product. In addition, it develops AdipoTE to optimize the delivery of autologous fat; AngioTE for vascular regeneration; NeuralTE for peripheral nerve injuries of the extremities, as well as for patients with neuromas or chronic compression due to joint replacements, migraines, craniofacial injuries, carpal tunnel syndrome, and those who have undergone hernia or abdominal-based procedures; UroTE for the delivery of autologous urogenital epithelium and submucosa; LiverTE to address various causes of liver failure; and BowelTE to deliver an optimized autologous construct to aid in the regeneration of bowel tissue. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Current SymbolNASDAQ:PTE



Sales & Book Value

Annual Sales$5.65 million
Book Value$1.42 per share


Net Income$-92,490,000.00
Net Margins-1,152.56%


Market Cap$56.17 million
Next Earnings Date11/10/2020 (Estimated)
-0.09 (-5.84 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PTE News and Ratings via Email

Sign-up to receive the latest news and ratings for PTE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Polarityte (NASDAQ:PTE) Frequently Asked Questions

How has Polarityte's stock price been impacted by COVID-19 (Coronavirus)?

Polarityte's stock was trading at $1.07 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PTE shares have increased by 35.5% and is now trading at $1.45.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Polarityte?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Polarityte in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Polarityte

When is Polarityte's next earnings date?

Polarityte is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Polarityte

How were Polarityte's earnings last quarter?

Polarityte Inc (NASDAQ:PTE) announced its quarterly earnings data on Thursday, August, 6th. The company reported ($0.33) earnings per share for the quarter, topping analysts' consensus estimates of ($0.40) by $0.07. Polarityte had a negative return on equity of 179.96% and a negative net margin of 1,152.56%. During the same period in the prior year, the firm earned ($0.92) EPS.
View Polarityte's earnings history

What price target have analysts set for PTE?

5 equities research analysts have issued 12-month price objectives for Polarityte's shares. Their forecasts range from $3.00 to $6.00. On average, they expect Polarityte's share price to reach $4.40 in the next twelve months. This suggests a possible upside of 203.4% from the stock's current price.
View analysts' price targets for Polarityte

Has Polarityte been receiving favorable news coverage?

Press coverage about PTE stock has trended extremely negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Polarityte earned a news impact score of -4.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future.
View the latest news about Polarityte

Are investors shorting Polarityte?

Polarityte saw a drop in short interest in February. As of February 15th, there was short interest totaling 4,010,000 shares, a drop of 15.8% from the January 31st total of 4,760,000 shares. Based on an average daily volume of 467,700 shares, the short-interest ratio is presently 8.6 days. Approximately 21.6% of the shares of the company are short sold.
View Polarityte's Short Interest

Who are some of Polarityte's key competitors?

What other stocks do shareholders of Polarityte own?

Who are Polarityte's key executives?

Polarityte's management team includes the following people:
  • Mr. David B. Seaburg, Chief Exec. Officer (Age 50, Pay $7.5k)
  • Dr. Edward Winslow Swanson, Chief Translational Medicine Officer & Co-Founder (Age 35, Pay $400k)
  • Mr. Paul Elliot Mann, Exec. Officer
  • Mr. Richard Hague, Pres & COO (Age 60)
  • Mr. Jacob Alexander Patterson, Interim Chief Financial Officer

What is Polarityte's stock symbol?

Polarityte trades on the NASDAQ under the ticker symbol "PTE."

Who are Polarityte's major shareholders?

Polarityte's stock is owned by many different institutional and retail investors. Top institutional investors include Bernardo Wealth Planning LLC (0.21%). Company insiders that own Polarityte stock include Cameron J Hoyler, David B Seaburg, Denver Lough, Edward Winslow Swanson, Paul Elliot Mann, Peter A Cohen, Rainer M Erdtmann, Richard Hague and Steve Gorlin.
View institutional ownership trends for Polarityte

Which institutional investors are buying Polarityte stock?

PTE stock was acquired by a variety of institutional investors in the last quarter, including Bernardo Wealth Planning LLC. Company insiders that have bought Polarityte stock in the last two years include Edward Winslow Swanson, Paul Elliot Mann, Peter A Cohen, and Rainer M Erdtmann.
View insider buying and selling activity for Polarityte

How do I buy shares of Polarityte?

Shares of PTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Polarityte's stock price today?

One share of PTE stock can currently be purchased for approximately $1.45.

How big of a company is Polarityte?

Polarityte has a market capitalization of $56.17 million and generates $5.65 million in revenue each year. The company earns $-92,490,000.00 in net income (profit) each year or ($3.70) on an earnings per share basis. Polarityte employs 153 workers across the globe.

What is Polarityte's official website?

The official website for Polarityte is www.polarityte.com.

How can I contact Polarityte?

Polarityte's mailing address is 123 NORTH WRIGHT BROTHERS DRIVE, SALT LAKE CITY UT, 84116. The company can be reached via phone at 385-237-2279 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.